Home / Business and Economy / Houston Lands $2.3B BMS Manufacturing Campus
Houston Lands $2.3B BMS Manufacturing Campus
13 Aug
Summary
- Bristol Myers Squibb selects Houston's Generation Park for a $2.3 billion manufacturing campus.
- The new facility will employ nearly 500 people and support 2,000 indirect jobs.
- This major life sciences investment anchors Generation Park's expansion plans.
Bristol Myers Squibb (BMS) has selected Houston's Generation Park for a substantial $2.3 billion pharmaceutical manufacturing campus. This strategic investment is set to enhance BMS's domestic production capacity across the United States.
The sprawling 600,000-square-foot facility is designed with modularity to accommodate evolving drug pipelines, including small molecules, biologics, and antibody-drug conjugates. BMS chose Houston after evaluating multiple markets, citing the city's robust life sciences workforce, essential infrastructure, and supportive business environment.
Construction and indirect job creation are projected to reach approximately 2,000 positions between 2027 and 2030. The initial campus workforce will comprise skilled roles in operations, production, maintenance, quality control, and leadership, with nearly 500 employees expected at launch.
This major life sciences anchor reinforces Generation Park's development as a 4,300-acre hub for advanced manufacturing and life sciences. BMS's investment is part of a larger five-year, $40 billion U.S. commitment encompassing research and development, technology, and manufacturing expansion.
